137310.KS

SD BioSensor, Inc [137310.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

137310.KS Stock Summary

Top 10 Correlated ETFs

137310.KS


Top 10 Correlated Stocks

137310.KS


In the News

137310.KS Financial details

Company Rating
Neutral
Market Cap
1551.36B
Income
-467.45B
Revenue
655.68B
Book val./share
22489.86
Cash/share
4542.01
Dividend
-
Dividend %
-
Employees
576
Optionable
No
Shortable
Yes
Earnings
15 May 2023
P/E
-1.74
Forward P/E
42.6
PEG
0.12
P/S
2.02
P/B
0.42
P/C
2.6
P/FCF
6
Quick Ratio
-
Current Ratio
2.14
Debt / Equity
0.15
LT Debt / Equity
0.09
-
-
EPS (TTM)
-4.34K
EPS next Y
277
EPS next Q
-122.49
EPS this Y
-146.89%
EPS next Y
-106.39%
EPS next 5Y
-106.39%
EPS last 5Y
NAN%
Revenue last 5Y
55.14%
Revenue Q/Q
5.68%
EPS Q/Q
45.85%
-
-
-
-
SMA20
-5.26%
SMA50
3.14%
SMA100
19.32%
Inst Own
-
Inst Trans
-
ROA
-18%
ROE
-24%
ROC
-0.11%
Gross Margin
-
Oper. Margin
-52%
Profit Margin
-100%
Payout
-10%
Shs Outstand
122.35M
Shs Float
34.41M
-
-
-
-
Target Price
-
52W Range
9570.0-25450.0
52W High
-53.63%
52W Low
+23.3%
RSI
49.45
Rel Volume
0.35
Avg Volume
253.97K
Volume
87.94K
Perf Week
1.29%
Perf Month
-2.4%
Perf Quarter
10.49%
Perf Half Y
7.57%
-
-
-
-
Beta
1.122
-
-
Volatility
313.8%, 545.62%
Prev Close
-0.25%
Price
11800
Change
-2.32%

137310.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
879.2918.07K30.04K28.94K5.6K
Net income per share
386.6K11.16K9K-4.18K
Operating cash flow per share
-19.585.31K12.66K8.79K-2.19K
Free cash flow per share
-1104.72K11.65K5.82K-3.49K
Cash per share
473.324.98K19.44K20.43K5.01K
Book value per share
1.61K8.02K22.46K29.07K24.82K
Tangible book value per share
1.59K8.06K22.2K28.42K16.22K
Share holders equity per share
1.61K8.02K22.46K29.07K24.82K
Interest debt per share
178.72224.3261.04254.54.17K
Market cap
5061.69B5692.56B5451.43B2897.15B1275.99B
Enterprise value
5057.07B5469.84B4594.81B1048.99B1218.04B
P/E ratio
1.61K9.255.013.18-2.75
Price to sales ratio
69.373.381.860.992.06
POCF ratio
-3.12K11.494.413.25-5.27
PFCF ratio
-554.5512.934.84.91-3.3
P/B Ratio
37.947.612.490.980.46
PTB ratio
37.947.612.490.980.46
EV to sales
69.313.241.570.361.96
Enterprise value over EBITDA
880.067.533.160.81-11.02
EV to operating cash flow
-3.11K11.043.721.18-5.03
EV to free cash flow
-554.0512.424.051.78-3.15
Earnings yield
00.110.20.31-0.36
Free cash flow yield
00.080.210.2-0.3
Debt to equity
0.110.030.010.010.15
Debt to assets
0.090.010.010.010.11
Net debt to EBITDA
-0.8-0.31-0.59-1.420.52
Current ratio
3.721.873.318.483.01
Interest coverage
6.041.7K2.79K1.15K-5.62
Income quality
-0.520.81.160.980.52
Dividend Yield
000.010.070.02
Payout ratio
000.050.22-0.06
Sales general and administrative to revenue
0.020000
Research and developement to revenue
0.070.010.010.020.1
Intangibles to total assets
0.0300.010.020.32
Capex to operating cash flow
4.62-0.11-0.08-0.340.6
Capex to revenue
-0.1-0.03-0.03-0.1-0.23
Capex to depreciation
-1.73-6.92-5.19-7.36-1.05
Stock based compensation to revenue
000.010.010
Graham number
1.17K34.49K75.11K76.7K48.31K
ROIC
0.010.810.450.28-0.08
Return on tangible assets
0.020.420.370.29-0.18
Graham Net
597.473.08K15.63K20K87.06
Working capital
78.67B599.86B1798.11B2220.29B644.22B
Tangible asset value
132.34B752.03B2165.36B2879.41B1798.62B
Net current asset value
75.77B585.16B1776.26B2202.12B187.22B
Invested capital
0.110.030.010.010.15
Average receivables
0245.9B407.91B274.84B185.45B
Average payables
0220.66B281.98B89.94B38.62B
Average inventory
0200.34B345.4B289.55B225.14B
Days sales outstanding
166.4399.2644.5123.95105
Days payables outstanding
83.93189.2636.1310.7319.88
Days of inventory on hand
240.12161.587.0860.4121.6
Receivables turnover
2.193.688.215.243.48
Payables turnover
4.351.9310.134.0118.36
Inventory turnover
1.522.264.196.043
ROE
0.020.820.50.31-0.17
Capex per share
-90.42-590.97-1.02K-2.97K-1.31K

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.94K1.78K1.59K1.3K1.02K
Net income per share
-3.21K-2.17K-806.25-551.57-768.2
Operating cash flow per share
2.67K-704.95-586.42-866.07-78.06
Free cash flow per share
2.09K-1.15K-877-1.24K-283.01
Cash per share
20.35K7.66K6.46K4.09K4.54K
Book value per share
28.95K27.2K26.52K25.14K22.49K
Tangible book value per share
28.31K7.29K6.92K7.48K14.7K
Share holders equity per share
28.95K27.2K26.52K25.14K22.49K
Interest debt per share
246.97.07K6.98K3.93K3.5K
Market cap
2908.85B2158.28B1251.24B1321.69B1408.22B
Enterprise value
1060.69B2230.26B1461.3B1453.03B1350.26B
P/E ratio
-2.23-2.43-3.79-5.15-3.75
Price to sales ratio
14.7411.837.698.7511.31
POCF ratio
10.72-29.93-20.86-13.13-147.44
PFCF ratio
13.67-18.3-13.95-9.13-40.67
P/B Ratio
0.990.780.460.450.51
PTB ratio
0.990.780.460.450.51
EV to sales
5.3712.238.999.6210.85
Enterprise value over EBITDA
-3.27-105.7240.9337.48101.31
EV to operating cash flow
3.91-30.93-24.36-14.43-141.38
EV to free cash flow
4.99-18.91-16.29-10.04-39
Earnings yield
-0.11-0.1-0.07-0.05-0.07
Free cash flow yield
0.07-0.05-0.07-0.11-0.02
Debt to equity
0.010.250.260.150.15
Debt to assets
0.010.170.180.120.11
Net debt to EBITDA
5.7-3.415.883.39-4.35
Current ratio
8.482.481.682.143.01
Interest coverage
-352.13-4.84-5.27-4.02-3.09
Income quality
-0.830.320.721.580.1
Dividend Yield
000.0200
Payout ratio
00-0.3600
Sales general and administrative to revenue
0.020.560.690.550
Research and developement to revenue
0.070.080.10.110.12
Intangibles to total assets
0.020.480.50.540.32
Capex to operating cash flow
-0.220.640.50.442.63
Capex to revenue
-0.3-0.25-0.18-0.29-0.2
Capex to depreciation
-4.23-1.7-0.9-1.27-0.58
Stock based compensation to revenue
0.010000
Graham number
45.72K36.48K21.94K17.66K19.72K
ROIC
-0.03-0.05-0.02-0.01-0.01
Return on tangible assets
-0.1-0.1-0.04-0.04-0.04
Graham Net
19.92K-2.85K-3.02K-1.32K78.88
Working capital
2220.29B808.06B464.21B488.75B644.22B
Tangible asset value
2879.41B745.38B707.51B869.15B1798.62B
Net current asset value
2202.12B-74.38B-118.93B13.32B187.22B
Invested capital
0.010.250.260.150.15
Average receivables
409.23B231.17B243.8B213.02B193.45B
Average payables
94B50.81B44.47B31.25B30.96B
Average inventory
349.76B277.41B285.6B255.22B217.52B
Days sales outstanding
87.72133.2120.45124.18129.06
Days payables outstanding
16.2224.9323.0923.9935.21
Days of inventory on hand
91.3132.75192.16191.93215.34
Receivables turnover
1.030.680.750.720.7
Payables turnover
5.553.613.93.752.56
Inventory turnover
0.990.680.470.470.42
ROE
-0.11-0.08-0.03-0.02-0.03
Capex per share
-575.03-448.22-290.58-378.85-204.95

137310.KS Frequently Asked Questions

What is SD BioSensor, Inc stock symbol ?

SD BioSensor, Inc is a KR stock and trading under the symbol 137310.KS

What is SD BioSensor, Inc stock quote today ?

SD BioSensor, Inc stock price is $11800 today.

Is SD BioSensor, Inc stock public?

Yes, SD BioSensor, Inc is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks